Bushe ubulwele bwa kansa ya kuli bapwapwa bwaba shani?
Icipimo ca malwele ya kansa ya kuli bapwapwa cilosha ku kwaluka kwa fintu fya cifyalilwa ifilenga umuntu alwale kansa ya kuli bapwapwa.
Kansa ya kuli bapwapwa bulwele bwabipa ubwisa pa mulandu wa kuti insandesande sha kuli bapwapwa shilakula no kulekana.
Ishi nsandesande kuti shapanga ifilonda no kusalanganina ku filundwa fimbi ifya mubili, ne ci kuti calenga umuntu ukulwala amalwele yalekanalekana.
Icilenga kansa ya kuli bapwapwa ukulwalika abantu, fintu pamo nga ukufulungana kwa nsandesande, ifyaba mu bwikashi, ne fyo abantu bekala.
Ifyabipa ifingacitika ku DNA ya nsandesande sha mumala kuti fyalenga insandesande ukukula no kulekana ukwabula ukuleka.
Ifi fintu kuti fyaba fya mu cisoolo nelyo fyacitika umuntu nga asambilila, kabili kuti fyacitika nga ca kuti umuntu asangwa na fintu ifilenga kansa pamo nga icushi ca fwaka, radon, asbestos, no mwela wabipa.
Ubulwele bwa kansa ya kuli bapwapwa kuti bwaba mu misango ibili: small cell lung cancer (SCLC) na non-small cell lung cancer (NSCLC).
Ifyabipa ifingacitika kuli ishi kansa sha mumala kuti fyapusana, pantu balipusana mu fyo bafumya ifishili fyabo kabili balasuka ku miti yalekanalekana.
Icilenga kansa ya kuli bapwapwa ukulwalika abantu, fintu ifilenga insandesande sha kansa ukulalwalika abantu bambi, pamo nga insandesande sha bucingo bwa mubili.
Insandesande sha kansa kuti shafulumuka insandesande sha mulwele, ne ci cilenga ukuti shilekula no kusalanganina ukwabula ukulesha.
Na kabili, icilundwa ca kansa icingalenga icilundwa ukulakula kuti calenga icilundwa ukulakula no kusalanganina ku ncende imbi.
Icilenga kansa ya kuli bapwapwa ukuleta amalwele cayanguka kabili abafwailisha pa malwele balabombesha pa kuti beshibe bwino ifyo icilenga.
Li Z, Qian Y, Li W, Liu L, Yu L, Liu X, Wu G, Wang Y, Luo W, Fang F, Liu Y, Song F, Cai Z, Chen W, Huang W: Human Lung Adenocarcinoma-Derived Organoid Models for Drug Screening. iScience. 2020, 23 (8): 101411.
Nurwidya F, Syahruddin E, Yunus F: Pain management in lung cancer. Adv Respir Med. 2016, 84 (6): 331-336.
Khan KA, Kennedy MP, Moore E, Crush L, Prendeville S, Maher MM, Burke L, Henry MT: Radiological characteristics, histological features and clinical outcomes of lung cancer patients with coexistent idiopathic pulmonary fibrosis. Lung. 2015, 193 (1): 71-7.
Paramanantham A, Asfiya R, Das S, McCully G, Srivastava A: Extracellular Vesicle (EVs) Associated Non-Coding RNAs in Lung Cancer and Therapeutics. Int J Mol Sci. 2022, 23 (21): .
Lee D, Kim Y, Chung C: Scientific Validation and Clinical Application of Lung Cancer Organoids. Cells. 2021, 10 (11): .
Mucchietto V, Crespi A, Fasoli F, Clementi F, Gotti C: Neuronal Acetylcholine Nicotinic Receptors as New Targets for Lung Cancer Treatment. Curr Pharm Des. 2016, 22 (14): 2160-9.
['Ukufumyamo: kwa cipatala']
['Iyi webusaiti yabelako ku kusambilisha fye abantu kabili te ya kubomfya pa kundapa.']
['Ifyebo fyaba pali iyi webusaiti tafifwile ukubomfiwa ku kwishiba ubulwele umuntu akwete nelyo ukuundapa ubulwele, kabili abafwaya ukupanda amano pa fya kundapwa bafwile ukuipusha badokota.']
['Moneni ukuti neural net iileasuka ifipusho, ilingi line tailondolola bwino bwino ifyebo, pamo nga impendwa ya bantu abalwala ubulwele bumo.']
['Lyonse muleipusha badokota nelyo ababomfi ba cipatala pa fyo mwingacita pa bumi bwenu. Mwilaleka ukumfwa ifyo badokota balanda pa mulandu wa fyebo mwabelenga pali iyi webusaiti. Nga mwamona ukuti namulwala ubulwele ubukalamba, mufwile ukwita bwangu ku cipatala. Iyi webusaiti nelyo ifyo mubomfya iyi webusaiti tafilenga mwaumfwana na badokota nelyo abalwele. BioMedLib na babomfi baiko, nelyo abaibikamo, tabapeelako uuli onse umulandu, nangu fye ni mu kulungatika nelyo mu kukanailanda, pa fyebo fyaba pali iyi webusaiti nelyo ifyo babomfya.']
['Ukufumyamo: insambu sha kulemba']
['Ifunde lya Digital Millennium Copyright Act ilya mu 1998, 17 U.S.C. § 512 (the DMCA) lyapeela inshila sha kupwishishamo ubwafya ku bene ba fipe abaishiba ukuti ifyebo fyaba pa Intaneti filatoba insambu shabo ukulingana ne funde lya U.S. pa fya mafunde ya kuicingilila. ']
['Nga mwamona ukuti ifyebo fimo nelyo ifintu fimbi ifyo babika pa webusaiti yesu nelyo pa milimo yesu fyalipula mu nsambu sha bene, imwe (nangu umwiminishi wenu) kuti mwatutumina kalata ya kutweba ukuti tufumye ifyo fyebo nelyo ifyo fintu, nelyo ukuti tuleke ukufibomfya. ']
['Ukutumina abantu amameseji pa Intaneti (moneni akabokoshi akaleti "Kutuminako Bamunyinefwe" pa kuti mwishibe ama adresi ya pa Intaneti) ].']
['Ifunde lya DMCA litila mu mashiwi ya musango wa kuti umuntu nacita ifyo mulefwaya, mufwile ukulembapo ifyebo pamo nga: (1) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (2) ifyo icitabo ico mulefwaya ukupeela abantu e co balefwaya ukupeela abantu; (3) ifyo mwingatutumina ifyebo, pamo nga adresi yenu, inambala ya foni, e lyo na adresi ya e-mail; (4) ifyo mwingalanda ukuti mulesumina ukuti ifyo mulefwaya ukupeela abantu te fyo umwine wa ici citabo, nelyo umwiminishi wakwe, nelyo ifunde limbi lyalanda. ']
['(5) amashiwi yenu ayalembwa, aya kuti nga mwafilwa ukulemba, mukapeelwa umulandu wa bufi, ukuti ifyebo fyaba muli aya mashiwi fya cine kabili mwalikwata amaka ya kucingilila insambu sha bene isho mulefwaya ukufyenga; ']
['Kabili (6) ukusuminisha kwa mwine wa fipe nelyo ukwa muntu uwapeelwa insambu sha kucita ifintu pa mulandu wakwe. ']
['Mukwai tumeni kalata ya ku email pa kwipusha icili conse nelyo ukutupeela amano.']
What is pathophysiology of lung cancer?
The pathophysiology of lung cancer refers to the changes in the normal physiological processes and mechanisms that occur in the development and progression of lung cancer.
Lung cancer is a complex disease that arises from the uncontrolled growth and division of abnormal cells in the lungs.
These cells can form tumors and spread to other parts of the body, leading to various symptoms and complications.
The pathophysiology of lung cancer involves several factors, including genetic mutations, environmental factors, and lifestyle choices.
Genetic mutations can occur in the DNA of lung cells, leading to uncontrolled cell growth and division.
These mutations can be inherited or acquired, and they can be caused by exposure to carcinogens, such as tobacco smoke, radon, asbestos, and air pollution.
Lung cancer can be classified into two main types: small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). NSCLC is further divided into three subtypes: adenocarcinoma, squamous cell carcinoma, and large cell carcinoma.
The pathophysiology of these types of lung cancer can differ, as they have different genetic mutations and respond differently to treatment.
The pathophysiology of lung cancer also involves the interaction between cancer cells and the surrounding tissue, including the immune system.
Cancer cells can evade the immune system, allowing them to grow and spread unchecked.
Additionally, the tumor microenvironment can promote tumor growth and metastasis by providing a supportive environment for cancer cells.
The pathophysiology of lung cancer is a complex and dynamic process, and researchers are continuously working to better understand the underlying mechanisms to develop more effective treatments and improve patient outcomes.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Pa lwa']
['BioMedLib ibomfya amakompyuta ayabomba (amakompyuta ayaishiba ukulemba) pa kupanga ifipusho ne fyasuko.']
['Twatendekelepo ne mpapulo sha mu fipatala 35 milioni isha mu PubMed/Medline.']
